Biopharmaceutical
Medical
Pharmaceutical

Abeona Therapeutics

$6.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (0.92%) Today
+$0.13 (2.06%) After Hours

Why Robinhood?

You can buy or sell ABEO and other stocks, options, ETFs, and crypto commission-free!

About

Abeona Therapeutics Inc. Common Stock, also called Abeona Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. Read More It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

Employees
83
Headquarters
New York, New York
Founded
1974
Market Cap
314.07M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
572.88K
High Today
$6.78
Low Today
$6.49
Open Price
$6.53
Volume
172.70K
52 Week High
$18.90
52 Week Low
$6.26

Collections

Biopharmaceutical
Medical
Pharmaceutical
Health
Gene Therapies
Therapy
Technology
2015 IPO

News

Seeking AlphaMay 14

Abeona Therapeutics Inc. CEO João Siffert on Q1 2019 Results - Earnings Call Transcript

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q1 2019 Earnings Conference Call May 14, 2019 10:00 AM ET Company Participants Sofia Warner - Senior Director, Investor Relations João Siffert - Chief Executive Officer, Head of Research & Development and Chief Medical Officer Timothy Miller - President and Chief Scientific Officer Christine Berni-Silverstein - Chief Financial Officer Conference Call Participants David Steinberg - Jefferies & Company, Inc. Liav Abraham - Citigroup Edward Marks - H.C. Wainwrigh...

99
NasdaqMay 7

Abeona Therapeutics Announces Participation in Upcoming Investor Conferences

NEW YORK and CLEVELAND, May 07, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a fully-integrated leader in gene and cell therapy, today announced its participation in the following upcoming investor conferences. SunTrust Robinson Humphrey 5th Annual Life Science Summit One-on-one Meetings May 8, 2019 Lotte New York Palace, New York, NY 2019 RBC Capital Markets Healthcare Conference Fireside Chat May 22, 2019, 1:35 p.m. ET The InterContinental New York Barclay Hotel, New York...

69

Earnings

-$0.40
-$0.31
-$0.22
-$0.13
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.32 per share
Actual
-$0.39 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.